Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Sho

Showing results (21-30 of 119) with videos related to

Pageof 12
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 17, 2016
Combination of neutrophil-to-lymphocyte ratio and early des-γ-carboxyprothrombin change ratio as a useful predictor of treatment response for hepatic arterial infusion chemotherapy against advanced hepatocellular carcinomaSeiji Tsunematsu, Goki Suda, Kazushi Yamasaki, et al.
Journal of Gastroenterology|August 28, 2020
Durable response without recurrence to Tolvaptan improves long-term survivalMasato Nakai, Goki Suda, Akinori Kubo, et al.
Internal Medicine (Tokyo, Japan)|September 17, 2014
Hepatosplenic gamma-delta T-cell lymphoma associated with Epstein-Barr virusSeiji Tsunematsu, Mitsuteru Natsuizaka, Hiromi Fujita, et al.
Journal of Viral Hepatitis|February 15, 2021
Changes in the estimated renal function after hepatitis C virus eradication with direct-acting antiviral agents: Impact of changes in skeletal muscle massYoshimasa Tokuchi, Goki Suda, Megumi Kimura, et al.
Scientific Reports|January 28, 2022
Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradicationMasato Nakai, Yoshiya Yamamoto, Masaru Baba, et al.
Journal of Medical Virology|July 27, 2016
Hepatitis B virus X protein impairs α-interferon signaling via up-regulation of suppressor of cytokine signaling 3 and protein phosphatase 2ASeiji Tsunematsu, Goki Suda, Kazushi Yamasaki, et al.
Journal of Medical Virology|September 25, 2016
Anti-adipogenic and antiviral effects of l-carnitine on hepatitis C virus infectionYoko Tsukuda, Goki Suda, Seiji Tsunematsu, et al.
The British Journal of Radiology|January 12, 2023
Study of hepatic toxicity in small liver tumors after photon or proton therapy based on factors predicting the benefits of protonYusuke Uchinami, Norio Katoh, Daisuke Abo, et al.
Hepatology Communications|August 11, 2018
L-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver CirrhosisMasatsugu Ohara, Koji Ogawa, Goki Suda, et al.
Journal of Gastroenterology|June 26, 2009
The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinomaMakoto Chuma, Shuhei Hige, Toshiya Kamiyama, et al.
Pageof 12

Showing results (21-30 of 119) with videos related to

Sort By:
Pageof 12
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 17, 2016
Combination of neutrophil-to-lymphocyte ratio and early des-γ-carboxyprothrombin change ratio as a useful predictor of treatment response for hepatic arterial infusion chemotherapy against advanced hepatocellular carcinomaSeiji Tsunematsu, Goki Suda, Kazushi Yamasaki, et al.
Journal of Gastroenterology|August 28, 2020
Durable response without recurrence to Tolvaptan improves long-term survivalMasato Nakai, Goki Suda, Akinori Kubo, et al.
Internal Medicine (Tokyo, Japan)|September 17, 2014
Hepatosplenic gamma-delta T-cell lymphoma associated with Epstein-Barr virusSeiji Tsunematsu, Mitsuteru Natsuizaka, Hiromi Fujita, et al.
Journal of Viral Hepatitis|February 15, 2021
Changes in the estimated renal function after hepatitis C virus eradication with direct-acting antiviral agents: Impact of changes in skeletal muscle massYoshimasa Tokuchi, Goki Suda, Megumi Kimura, et al.
Scientific Reports|January 28, 2022
Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradicationMasato Nakai, Yoshiya Yamamoto, Masaru Baba, et al.
Journal of Medical Virology|July 27, 2016
Hepatitis B virus X protein impairs α-interferon signaling via up-regulation of suppressor of cytokine signaling 3 and protein phosphatase 2ASeiji Tsunematsu, Goki Suda, Kazushi Yamasaki, et al.
Journal of Medical Virology|September 25, 2016
Anti-adipogenic and antiviral effects of l-carnitine on hepatitis C virus infectionYoko Tsukuda, Goki Suda, Seiji Tsunematsu, et al.
The British Journal of Radiology|January 12, 2023
Study of hepatic toxicity in small liver tumors after photon or proton therapy based on factors predicting the benefits of protonYusuke Uchinami, Norio Katoh, Daisuke Abo, et al.
Hepatology Communications|August 11, 2018
L-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver CirrhosisMasatsugu Ohara, Koji Ogawa, Goki Suda, et al.
Journal of Gastroenterology|June 26, 2009
The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinomaMakoto Chuma, Shuhei Hige, Toshiya Kamiyama, et al.
Pageof 12